• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型吡啶 nortopsentin 类似物作为细胞周期蛋白依赖性激酶 6 抑制剂的抗结直肠癌活性及计算机模拟研究。

Anti colorectal cancer activity and in silico studies of novel pyridine nortopsentin analog as cyclin dependent kinase 6 inhibitor.

机构信息

Chemistry of Natural Compounds Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, 12622, Giza, Egypt.

Green Chemistry Department, National Research Centre, Dokki, 12622, Giza, Egypt.

出版信息

Sci Rep. 2024 Nov 1;14(1):26327. doi: 10.1038/s41598-024-75411-3.

DOI:10.1038/s41598-024-75411-3
PMID:39487179
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11530689/
Abstract

Nortopsentins are a vital class of deep-sea sponge metabolites which can be used as leads for antitumor agents. Although their action has been studied in several diseases' contexts, their cytotoxic activity against colorectal carcinoma has not yet been fully investigated. Therefore, a series of 2,6-bis(1H-indol-3-yl)-4-(substituted-phenyl)pyridin-5-carbonitriles 4a-j (nortopsentin analogs) was investigated for their cytotoxic activity against colorectal carcinoma. The analog 4i showed the highest antitumor activity via inducing cell cycle arrest at G1 phase. Cell cycle arrest was induced due to expression downregulation of CDK2, CDK4, and CDK6. In addition, 4i suppressed the enzymatic activity of CDK6. The theoretical study of some basic quantum factors and the geometric shape of compound 4i proved that the compound is stable and a soft molecule, in which the E and E energies were negative and had a small ∆E gap. 4i also demonstrated a high potential for oral bioavailability due to its adherence to Lipinski's rule of five. The molecular docking studies of 4i analog showed good binding mode with CDK6 active pocket through the formation of multiple interactions with its key amino acids.

摘要

诺托品是深海海绵代谢物的重要类别,可用作抗肿瘤药物的先导化合物。尽管已经在几种疾病的背景下研究了它们的作用,但它们对结直肠癌的细胞毒性活性尚未得到充分研究。因此,研究了一系列 2,6-双(1H-吲哚-3-基)-4-(取代苯基)吡啶-5-甲腈 4a-j(诺托品类似物)对结直肠癌的细胞毒性活性。类似物 4i 通过诱导 G1 期细胞周期停滞表现出最高的抗肿瘤活性。细胞周期停滞是由于 CDK2、CDK4 和 CDK6 的表达下调引起的。此外,4i 抑制了 CDK6 的酶活性。化合物 4i 的一些基本量子因素和几何形状的理论研究证明了该化合物是稳定的和软分子,其中 E 和 E 能量为负,并且具有较小的 ∆E 间隙。4i 还由于符合 Lipinski 的五规则而显示出高口服生物利用度的潜力。4i 类似物的分子对接研究表明,通过与关键氨基酸形成多种相互作用,该类似物与 CDK6 活性口袋具有良好的结合模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/11530689/444f06446976/41598_2024_75411_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/11530689/cd4d2e93689a/41598_2024_75411_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/11530689/8c84e611b694/41598_2024_75411_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/11530689/4efba2e31bdc/41598_2024_75411_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/11530689/c0082c4fa798/41598_2024_75411_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/11530689/680067dea4d2/41598_2024_75411_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/11530689/ab4b05639ef7/41598_2024_75411_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/11530689/444f06446976/41598_2024_75411_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/11530689/cd4d2e93689a/41598_2024_75411_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/11530689/8c84e611b694/41598_2024_75411_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/11530689/4efba2e31bdc/41598_2024_75411_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/11530689/c0082c4fa798/41598_2024_75411_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/11530689/680067dea4d2/41598_2024_75411_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/11530689/ab4b05639ef7/41598_2024_75411_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/11530689/444f06446976/41598_2024_75411_Fig7_HTML.jpg

相似文献

1
Anti colorectal cancer activity and in silico studies of novel pyridine nortopsentin analog as cyclin dependent kinase 6 inhibitor.新型吡啶 nortopsentin 类似物作为细胞周期蛋白依赖性激酶 6 抑制剂的抗结直肠癌活性及计算机模拟研究。
Sci Rep. 2024 Nov 1;14(1):26327. doi: 10.1038/s41598-024-75411-3.
2
The novel selective inhibitors of cyclin-dependent kinase 4/6: in vitro and in silico study.新型细胞周期蛋白依赖性激酶 4/6 选择性抑制剂:体外与计算研究。
Sci Rep. 2024 Oct 9;14(1):23505. doi: 10.1038/s41598-024-71865-7.
3
A novel anticancer agent, SKLB70359, inhibits human hepatic carcinoma cells proliferation via G0/G1 cell cycle arrest and apoptosis induction.一种新型抗癌药物SKLB70359通过诱导G0/G1期细胞周期阻滞和凋亡来抑制人肝癌细胞增殖。
Cell Physiol Biochem. 2012;29(1-2):281-90. doi: 10.1159/000337609. Epub 2012 Mar 1.
4
Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.靶向细胞周期蛋白依赖性激酶1(CDK1)而非CDK4/6或CDK2对MYC依赖性人乳腺癌细胞具有选择性致死性。
BMC Cancer. 2014 Jan 20;14:32. doi: 10.1186/1471-2407-14-32.
5
CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.CDK4/6抑制剂SHR6390通过抑制磷酸化Rb并诱导G1期细胞周期阻滞,在食管鳞状细胞癌中发挥强大的抗肿瘤活性。
J Transl Med. 2017 Jun 2;15(1):127. doi: 10.1186/s12967-017-1231-7.
6
Selective CDK4/6 inhibition of novel 1,2,3-triazole tethered acridinedione derivatives induces G1/S cell cycle transition arrest via Rb phosphorylation blockade in breast cancer models.新型 1,2,3-三唑连接的吖啶二酮衍生物的选择性 CDK4/6 抑制通过阻断 Rb 磷酸化诱导乳腺癌模型中 G1/S 细胞周期过渡阻滞。
Bioorg Chem. 2021 Nov;116:105377. doi: 10.1016/j.bioorg.2021.105377. Epub 2021 Sep 17.
7
Molecular docking and MD simulation studies of 4-thiazol-N-(pyridin-2-yl)pyrimidin-2-amine derivatives as novel inhibitors targeted to CDK2/4/6.基于分子对接和 MD 模拟研究 4-噻唑-N-(吡啶-2-基)嘧啶-2-胺衍生物作为新型靶向 CDK2/4/6 的抑制剂
J Cancer Res Clin Oncol. 2024 Jun 10;150(6):302. doi: 10.1007/s00432-024-05818-y.
8
Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2.临床 CDK4/6 抑制剂诱导 p21 从 cyclin D-CDK4 中选择性且即刻解离,从而抑制 CDK2。
Nat Commun. 2021 Jun 7;12(1):3356. doi: 10.1038/s41467-021-23612-z.
9
Discovery of New Pyrazolopyridine, Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design, Synthesis, Docking Studies, and Anti-Proliferative Activity.新型吡唑并吡啶、呋咱吡啶和吡啶衍生物作为 CDK2 抑制剂的发现:设计、合成、对接研究和抗增殖活性。
Molecules. 2021 Jun 26;26(13):3923. doi: 10.3390/molecules26133923.
10
Development of pteridin-7(8H)-one analogues as highly potent cyclin-dependent kinase 4/6 inhibitors: Synthesis, structure-activity relationship, and biological activity.蝶啶-7(8H)-酮类似物作为高活性细胞周期蛋白依赖性激酶 4/6 抑制剂的研发:合成、构效关系和生物学活性。
Bioorg Chem. 2021 Nov;116:105324. doi: 10.1016/j.bioorg.2021.105324. Epub 2021 Sep 2.

引用本文的文献

1
Marine-Derived Compounds: A New Horizon in Cancer, Renal, and Metabolic Disease Therapeutics.海洋来源化合物:癌症、肾脏及代谢性疾病治疗的新前沿
Mar Drugs. 2025 Jul 9;23(7):283. doi: 10.3390/md23070283.

本文引用的文献

1
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1.1,3,4-恶二唑和 1,3,4-噻二唑诺替森汀衍生物对胰腺导管腺癌的作用:合成、细胞毒性活性和 CDK1 抑制作用。
Mar Drugs. 2023 Jul 19;21(7):412. doi: 10.3390/md21070412.
2
Targeting CDK1 in cancer: mechanisms and implications.靶向癌症中的细胞周期蛋白依赖性激酶1:机制与意义
NPJ Precis Oncol. 2023 Jun 13;7(1):58. doi: 10.1038/s41698-023-00407-7.
3
Synthesis, DFT Studies, Molecular Docking and Biological Activity Evaluation of Thiazole-Sulfonamide Derivatives as Potent Alzheimer's Inhibitors.
噻唑-磺胺衍生物的合成、DFT 研究、分子对接和作为潜在阿尔茨海默病抑制剂的生物活性评价。
Molecules. 2023 Jan 5;28(2):559. doi: 10.3390/molecules28020559.
4
Target-Based Small Molecule Drug Discovery for Colorectal Cancer: A Review of Molecular Pathways and In Silico Studies.基于靶点的结直肠癌小分子药物研发:分子通路与计算机研究综述。
Biomolecules. 2022 Jun 23;12(7):878. doi: 10.3390/biom12070878.
5
Targeting CDK4 and CDK6 in cancer.针对癌症中的 CDK4 和 CDK6。
Nat Rev Cancer. 2022 Jun;22(6):356-372. doi: 10.1038/s41568-022-00456-3. Epub 2022 Mar 18.
6
Promising bioactive compounds from the marine environment and their potential effects on various diseases.来自海洋环境的有前景的生物活性化合物及其对各种疾病的潜在影响。
J Genet Eng Biotechnol. 2022 Jan 26;20(1):14. doi: 10.1186/s43141-021-00290-4.
7
Cell cycle control in cancer.癌症中的细胞周期调控。
Nat Rev Mol Cell Biol. 2022 Jan;23(1):74-88. doi: 10.1038/s41580-021-00404-3. Epub 2021 Sep 10.
8
Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials.细胞周期蛋白依赖性激酶(CDK)抑制剂在实体瘤中的研究进展:临床试验综述。
Clin Transl Oncol. 2022 Feb;24(2):161-192. doi: 10.1007/s12094-021-02688-5. Epub 2021 Aug 7.
9
Synthesis, Molecular Docking, and Biofilm Formation Inhibitory Activity of Bis(Indolyl)Pyridines Analogues of the Marine Alkaloid Nortopsentin.双(吲哚基)吡啶类海洋生物碱诺托普辛类似物的合成、分子对接及生物膜形成抑制活性
Molecules. 2021 Jul 6;26(14):4112. doi: 10.3390/molecules26144112.
10
Targeting cell-cycle machinery in cancer.针对癌症中的细胞周期机制。
Cancer Cell. 2021 Jun 14;39(6):759-778. doi: 10.1016/j.ccell.2021.03.010. Epub 2021 Apr 22.